Content Type: Article

  • Connecticut Employers Required to Disclose Wage Ranges Under New Law

    Connecticut Employers Required to Disclose Wage Ranges Under New Law

    ARTICLE / CLIENT ALERT

    Connecticut Employers Required to Disclose Wage Ranges Under New Law

    September 29, 2021

    Read time: 5 min

    Key takeaways
    Overview

    On Sept. 28, 2021, the Connecticut Department of Labor released new guidance (“Guidance”) regarding Connecticut Public Act 21-30 “An Act Concerning The Disclosure Of Salary Range For A Vacant Position” (“Act”). The Act, which goes into effect on Oct. 1, 2021, amends current Connecticut law to require all Connecticut employers to disclose the applicable “wage range” (defined below) to all job applicants and employees. The Act also expands Connecticut’s ban on discrimination in the amount of compensation paid to any employee on the basis of sex.

    Background

    Connecticut General Statute § 31-40z, which the Act amends, bars employers from, among other things, prohibiting or penalizing employees from disclosing or discussing the amount of their wages with another employee. This statute defines “employer,” “employee,” and “wages” broadly to cover virtually every employer operating in Connecticut. The Act therefore applies to all employers located within the state of Connecticut who use the services of one or more employees for pay. The Guidance clarifies that the Act also applies to all employers within the state of Connecticut even if the employees are located outside of the state of Connecticut.

    The Act’s Requirements

    The Act adds two new requirements for Connecticut employers:

    1. Employers must provide an applicant for employment with the “wage range” of the position for which the applicant is applying “upon the earliest of (A) the applicant’s request, or (B) prior to or at the time the applicant is made an offer of compensation”; and
    2. Employers must provide an employee with the wage range for the employee’s position “upon (A) the hiring of the employee, (B) a change in the employee’s position with the employer, or (C) the employee’s first request for a wage range.”

    Employers are required only to provide the wage range for the position an employee holds or for which an applicant applied.

    “Wage range” is defined as the “range of wages an employer anticipates relying on when setting wages for a position, and may include reference to any applicable pay scale, previously determined range of wages for the position, actual range of wages for those employees currently holding comparable positions or the employer’s budgeted amount for the position.” The Act defines “wages” as “compensation for labor or services rendered by an employee, whether the amount is determined on a time, task, piece, commission or other basis of calculation.” Yesterday’s Guidance clarifies that “wage range” includes compensation by bonus and commission, but generally does not include discretionary pay from an employer. Therefore, employers are required to disclose not only the salary range that they expect to pay for the position, but also any expected bonuses and range of compensation for commission based sales.

    Connecticut employers should immediately identify applicable wage ranges for their positions, and be prepared to provide wage ranges to applicants and employees.

    Failure to Comply

    If an employer fails to comply with these requirements, an applicant or employee may file a civil action within two years of the date on which the alleged violation occurred for compensatory damages, attorney’s fees and costs, punitive damages and such other relief as the court deems just and proper. Affected applicants and employees may also file a complaint with the Connecticut Department of Labor, which may also issue a civil penalty against the employer if a violation is found.

    Changes to Discrimination in Compensation on the Basis of Sex

    In addition to the new requirements concerning the disclosure of “wage ranges” to applicants and employees, the Act amends the definition of discrimination in compensation on the basis of sex under Connecticut law. The definition of sex-based discrimination in compensation now includes any difference in pay for employees of the opposite sex for “comparable work on a job,” unless the employer can demonstrate that such differential in pay is made pursuant to (i) a seniority system; (ii) a merit system; (iii) a system which measures earnings by quantity or quality of production; or (iv) a differential system based upon a bona fide factor other than sex, including, but not limited to, education, training, credential, skill, geographic location or experience.[1] Employers should ensure that their employees’ pay is consistent with the new definition.

    Authored by Mark E. Brossman, Ronald E. Richman, Max Garfield, Scott A. Gold and Abdulrahman Alwattar.

    If you have any questions concerning this Alert, please contact your attorney at Schulte Roth & Zabel or one of the authors.


    [1] This section of the Act amends Connecticut General Statute § 31-75.


    This communication is issued by Schulte Roth & Zabel LLP for informational purposes only and does not constitute legal advice or establish an attorney-client relationship. In some jurisdictions, this publication may be considered attorney advertising. ©2021 Schulte Roth & Zabel LLP.

    All rights reserved. SCHULTE ROTH & ZABEL is the registered trademark of Schulte Roth & Zabel LLP.

    In depth
    Authors

    Mark E. Brossman

    Partner

    New York – 919 Third Avenue

    Ronald E. Richman

    Partner

    New York – 919 Third Avenue

    Max Garfield

    Partner

    New York – 919 Third Avenue

    Abdulrahman Alwattar

    Associate

    New York – 919 Third Avenue

    More insights

  • Estate Planning Considerations in Light of the House Ways and Means Committee’s Proposed Tax Bill

    Estate Planning Considerations in Light of the House Ways and Means Committee’s Proposed Tax Bill

    ARTICLE / CLIENT ALERT

    Estate Planning Considerations in Light of the House Ways and Means Committee’s Proposed Tax Bill

    Read time: 6 min

    Key takeaways
    Overview

    On Sept. 13, 2021, the House Ways and Means Committee announced its government-funding proposal (“Tax Bill”) which contains a number of amendments to the Internal Revenue Code that affect estate planning for individuals and eliminate several common estate planning techniques.[1]

    Below, we briefly summarize the most significant changes in the Tax Bill that may affect our clients’ estate planning, and the date on which these changes would become effective if the Tax Bill as currently proposed were to be enacted.

    It is important to recognize that the Tax Bill is only proposed legislation at this time. It remains to be seen whether Congress will enact the Tax Bill in its current form or in some modified version.

    Reduction of Lifetime Gift, Estate and GST Tax Exemption Amounts

    The Tax Bill proposes to reduce the gift, estate and generation-skipping transfer tax exemption amounts from $11.7 million to $5 million, adjusted for inflation, effective Jan. 1, 2022 (which would mean an exemption of approximately $6 million). Clients who wish to maximize the use of their exemptions should consider making gifts as soon as possible (particularly to so-called “grantor” trusts), as it is possible that the effective date could be moved up or the exemption could go down further.

    Changes to the Grantor Trust Rules

    Estate Tax Inclusion of Irrevocable Grantor Trusts

    The following proposed amendments apply to (i) grantor trusts created on or after the legislation is enacted or (ii) the portion of pre-existing grantor trusts attributable to contributions made on or after the legislation is enacted.

    • The value of the assets held in a grantor trust would be included in the grantor’s estate for federal estate tax purposes.
    • During the grantor’s lifetime, distributions from a grantor trust (other than to the grantor or the grantor’s spouse) would be treated as taxable gifts.
    • If the trust’s grantor trust status terminates during the grantor’s lifetime, there would be a deemed gift of the value of the assets held by the trust at that time.

    Frequently used grantor trusts, such as spousal lifetime access trusts (SLATs), grantor retained annuity trusts (GRATs), qualified personal residence trusts (QPRTs) and irrevocable life insurance trusts (ILITs), would no longer be viable estate planning techniques. While it is expected that the insurance lobby will seek an exception to this proposed amendment, it is unknown whether ILITs will be carved out of the final legislation. Clients wishing to make gifts to grantor trusts (including to pre-fund future premium payments for life insurance held in an ILIT) should consider doing so as soon as possible.

    Effective Date. As stated above, these changes would apply to (i) trusts created on or after the date of enactment of the Tax Bill and (ii) any contribution made after the date of enactment to a trust created prior to enactment.

    Gains Recognized on Sales to Grantor Trusts

    Sales or other transfers between a grantor and a grantor trust would no longer be disregarded for income tax purposes. This would eliminate the benefits of the future sale (or substitution) of appreciated assets to or from an irrevocable grantor trust. Clients wishing to engage in sales to irrevocable trusts with grantor trust powers should consider doing so as soon as possible.

    Effective Date. These changes would apply to (i) trusts created on or after the date of enactment of the Tax Bill and (ii) any contribution made after the date of enactment to a trust created prior to the date of enactment. However, this effective date could be modified in subsequent versions of the legislation to apply to grantor trusts created prior to the date of enactment.

    Elimination of Valuation Discounts for Transfers of Non-Business Assets

    The Tax Bill would eliminate discounts for entities holding non-business assets. A taxpayer would no longer be able to contribute non-business assets (i.e., assets not actively used in a trade or business in which the taxpayer is actively involved) to an entity and then apply discounts for lack of marketability or lack of control to a transfer of an interest in that entity (during lifetime or upon death). The proposed amendment applies to entity interests, so discounts may continue to be available to transfers of partial interests in real property. Clients wishing to make gifts at a discounted valuation of family investment vehicles or of interests in a family business in which the client is not actively engaged should consider doing so as soon as possible.

    Effective Date. This change would apply to transfers of non-business assets that occur after the date of enactment.

    Maintains Basis Step-Up at Death

    The Tax Bill, as proposed, does not eliminate the so-called “step-up” in basis at a decedent’s death on assets in his or her estate. To the extent possible, clients should continue to hold appreciated assets until death and should consider substituting low-basis assets held in grantor trusts with cash (or other high-basis assets) prior to enactment of any tax legislation.

    While the Tax Bill’s proposed amendments could be significantly revised or modified by the time Congress enacts new legislation in its final form, it is likely that the final legislation will contain targeted tax increases for high-income taxpayers, including on at least the estate planning areas described above.

    If you have any questions or would like to discuss your personal situation in light of this, please contact your SRZ attorneys.


    [1] Full text of the Tax Bill is available here.


     This communication is issued by Schulte Roth & Zabel LLP for informational purposes only and does not constitute legal advice or establish an attorney-client relationship. In some jurisdictions, this publication may be considered attorney advertising. ©2021 Schulte Roth & Zabel LLP.

    All rights reserved. SCHULTE ROTH & ZABEL is the registered trademark of Schulte Roth & Zabel LLP.

    In depth
    Authors
    More insights

  • Puzzling Illustrations of the Administration’s GILT I Proposals

    Puzzling Illustrations of the Administration’s GILT I Proposals

    ARTICLE / CLIENT ALERT

    Puzzling Illustrations of the Administration’s GILT I Proposals

    September 28, 2021

    Read time: 11 min

    Key takeaways
    Overview

    This column illustrates the tax results of a few simple fact patterns under the Biden Administration’s proposed revisions to the GILTI regime including the proposed increased tax rate on GILTI to 21 percent when combined with (1) the 20-percent “haircut” on taxes deemed paid with respect to GILTI and (2) expense apportionment.

    In depth

    As noted in the prior column, the Biden Administration’s proposals with respect to GILTI are harsh and significantly harsher than the OECD’s proposed minimum tax being negotiated with the United States and the international tax community. This column illustrates the tax results of a few simple fact patterns under the Administration’s proposed revisions to the GILTI regime. In particular, this column focuses on the proposed increased tax rate on GILTI to 21 percent when combined with (1) the 20-percent “haircut” on taxes deemed paid with respect to GILTI and (2) expense apportionment.

    As illustrated by simple examples, retention of the 20-percent haircut would have a considerable impact on effective tax rates (in addition to the proposed tax rate increase and the proposal to apply GILTI on a country-by-country basis). In addition, expense allocation and apportionment together with application of GILTI on a country-by-country basis will lead to situations where high-taxed foreign subsidiary income is subject to additional U.S. tax.

    20-Percent Haircut
    The Biden Administration has proposed increasing the tax rate on GILTI to 21 percent, while the United States and the international tax community are working towards a minimum tax of at least 15 percent. The Administration has not proposed repealing the 20-percent haircut with respect to GILTI taxes found in Code Sec. 960(d)(1). Code Sec. 960(d)(1) provides that, if any amount is includible in the gross income of a domestic corporation under Code Sec. 951A, such domestic corporation is deemed to have paid foreign income taxes equal to 80 percent of the product of such domestic corporation’s inclusion percentage (as defined in Code Sec. 960(d)(2)) multiplied by the aggregate foreign income taxes paid or accrued by CFCs. Thus, at most, only 80 percent of the foreign income taxes paid or accrued by CFCs with respect to GILTI would be deemed paid and thus eligible for a foreign tax credit (and the remaining 20 percent would be “haircut” and lost forever).

    Applying the 21-percent proposed tax rate to GILTI, together with the 20-percent haircut, a CFC would need to pay or accrue foreign income tax at a tax rate at least equal to 26.25 percent in order to avoid incremental U.S. tax on the foreign income. This is in stark contrast to the 15 percent minimum tax that the international tax community is negotiating.

    In fact, if a U.S.-parented CFC were organized and operating in a foreign country that was fully compliant with the proposed minimum tax of 15 percent, the U.S. parent would still pay an additional U.S. tax on the income by reason of both the increased tax rate and the haircut. For instance, if a CFC were organized in Country X, which imposed a 15-percent corporate income tax, a domestic corporation would pay an additional nine percent of U.S. tax on that income, resulting in an effective tax rate of 24 percent on the income (U.S. tax of nine percent and foreign income tax of 15 percent). Code Sec. 960(d) was added as part of the TCJA’s new GILTI regime. Legislative history describes the new GILTI regime as addressing a concern that taxpayers would move intangible property to a no or low-tax jurisdiction and the income from the intangible property would not be subject to U.S. tax under a participation exemption system. The legislative history explained that subjecting that income to current U.S. tax reduces the tax benefit of allocating that income to low- or zero-tax jurisdictions. The legislative history also “recognizes that taxing that income at the full U.S. corporate tax rate may hurt the competitive position of U.S. corporations relative to their foreign counterparts, and has decided to tax that income at a reduced rate (with a portion of foreign tax credits available to offset U.S. tax).” Legislative history describes the 20 percent haircut as addressing a concern that a full credit for foreign taxes with respect to GILTI would reduce the incentive for taxpayers to minimize the foreign tax they pay or encouraging foreign countries to adopt “soak-up” taxes.

    As taxpayers have realized, although GILTI was described as a backstop to a territorial system (see above), in practice, the GILTI rules tax the majority of foreign subsidiary income on a current basis (in contrast to the pre-TCJA system in which taxation of foreign subsidiary income was generally deferred until earnings were repatriated to the United States). The participation exemption added under the TCJA applies in very limited circumstances (e.g., with respect to QBAI and tested income offset by tested losses). Under the current expanded regime, the foreign tax credit is key to reaching the intended U.S. taxation of most income of CFCs. Reducing incentives to minimize foreign tax seems to be a significant concern in only narrow sets of situations. Thus, although the concern that gave rise to the 20-percent haircut may have been relatively narrow, the 20-percent haircut impacts the effective tax rate on most foreign subsidiary income.

    Lawmakers are now in the process of negotiating tax increases. If lawmakers were to determine that the tax rate on foreign subsidiary rate should be different than the 21-percent proposed rate, lawmakers should disclose and submit for public debate the intended rate. The 20-percent haircut understates the “headline” tax rate of 21 percent on foreign subsidiary income. The resulting hodge podge system makes it very difficult to discern what policy rationale underlies the adoption of new provisions or retention of components of the TCJA system, such as the 20-percent haircut. Lawmakers also should disclose the comparative benefits they anticipate from undercutting the competitive position of U.S. corporations relative to their foreign counterparts. As a general matter, lawmakers should describe the intended tax system—e.g., territorial or worldwide—so that policy decisions could be made in alignment with such tax system. Without providing a framework for the intended system, the hodge podge system may just drift along without accomplishing any identified purpose.

    Expense Apportionment
    As a practical matter, an increase in the U.S. tax rate on net GILTI from 10.5 percent to 21 percent (or 18.75 percent) would likely significantly mitigate the adverse impact of expense apportionment experienced by taxpayers post-TCJA. That said, application of expense apportionment and GILTI on a country-by-country basis would lead to situations where high-taxed foreign subsidiary income is still subject to U.S. tax.

    As background, the foreign tax credit limitation under Code Sec. 904 is determined, in part, based on a taxpayer’s taxable income from sources without the United States, and the limitation is applied on a category-by-category basis. Regulations under Code Secs. 861 through 865 provide rules for allocating and apportioning deductions to determine, among other things, a taxpayer’s taxable income from sources without the United States for purposes of applying Code Sec. 904. For example, with respect to GILTI, U.S. shareholder expenses allocated and apportioned to Code Sec. 951A category income reduce the taxpayer’s taxable income in the Code Sec. 951A category for foreign tax credit purposes, and limit the ability for the U.S. shareholder to utilize foreign tax credits with respect to Code Sec. 951A category income. As illustrated in the below example, in general, a U.S. shareholder’s foreign tax credit with respect to GILTI is limited to the lower of: (1) 80 percent of foreign income taxes paid and (2) U.S. tax on taxable income in the Code Sec. 951A category (e.g., taking into account the Code Sec. 250 deduction and U.S. shareholder expenses apportioned to GILTI).

    After starting in the direction of a territorial (participation exemption) system, but then abandoning that system, the expense allocation rules were retained for the GILTI regime and application of the foreign tax credit. Although the expense allocation and apportionment rules have been in place for many years, those rules had a much smaller impact on the pre-TCJA deferral regime as compared to the post-TCJA regime. One puzzling aspect of expense allocation is that it provides an incentive for shifting activities offshore because allocable expenses incurred by a U.S. shareholder reduces foreign tax credit utilization and thus increases the U.S. taxes paid on GILTI but the same expenses incurred by a CFC do not.

    Another puzzling aspect of expense allocation and apportionment is that it disproportionately impacts taxpayers with high foreign tax rates. To illustrate this point, assume that a U.S. shareholder has a CFC with 200 of GILTI (before taking into account the Code Sec. 250 deduction). In scenarios 1 and 2, CFC operates in a jurisdiction with a tax rate of 12 percent and 26.25 percent, 14 respectively. The amount of U.S. shareholder’s interest expense that is allocated and apportioned to gross income in the Code Sec. 951A category for purposes of Code Sec. 904(a) is 40. The U.S. tax rate is assumed to be 28 percent and assumed to be 21 percent on GILTI. Below are the U.S. tax results (see Table 1).

    As illustrated above, with respect to the CFC that operates in a higher-taxed jurisdiction, the apportionment of U.S. shareholder expenses reduces the Code Sec. 904(a)limitation in the Code Sec. 951A category and thus reduces the ability for the taxpayer to utilize foreign tax credits. Without expense apportionment, with respect to the higher-taxed CFC, the full 42 of FTC would be allowed such that the U.S. taxpayer would not incur U.S. tax with respect to that income. However, with expense apportionment, with respect to the higher-taxed CFC, only 30.80 of FTC would be allowed such that the U.S. taxpayer would incur 11.20 of tax with respect to that income.

    In contrast, with respect to the CFC that operates in the lower-taxed jurisdiction, the taxpayer is not impacted by expense allocation and apportionment. The foreign tax credit with respect to the lower-taxed CFC is limited by the amount of foreign taxes paid (taking into account the 20-percent haircut), such that the U.S. tax with respect to the lower-taxed income is 22.80 with or without expense apportionment. From a policy perspective, it is very odd, at the very least, to have rules that disproportionately impact taxpayers that have high foreign tax rates. High foreign tax rates are indicative of substance in developed economies. It seems odd to have rules that disproportionately impact taxpayers that have such substance (rather than taxpayers that transfer income to low-taxed jurisdictions, the intended target of the global intangible low-taxed income rules).

    Table 1.
        No Expense Apportionment   With Expense Apportionment
    A Foreign tax rate 12.00% 26.25%   12.00% 26.25%
    B GILTI 200 200   200 200
    C U.S. tax on GILTI pre-FTC (B x 21%) 42 42   42 42
    D Taxable income in GILTI Category (taking into account a 25% Code sec. 250 deduction and apportioned expenses of $40, if applicable) 150 150   110 110
    E FTC allowed (lower of the two) 1. 80% taxes deemed paid 2. 904 limit (D x 28%) 19.2 42   19.2 42
    42 42   30.8 30.8
                 
    F U.S. tax post-FTC (C – E) 22.8 0   22.8 11.2

    As a practical matter, with a higher U.S. tax rate on GILTI, expense apportionment would have a more limited impact as compared to post-TCJA. Taxes deemed paid limit—see E.1—would generally limit foreign tax credits and the FTC limitation (and expense apportionment)— see E.2—would limit foreign tax credits with respect to the narrow category of higher-taxed income. With respect to the taxes deemed paid limit, as noted above, if the tax rate on GILTI were to increase to 21 percent, the foreign tax rate would generally need to be at least 26.25 percent for the taxes deemed paid limit not to apply. Alternatively, if the tax rate on GILTI were to increase to 18.75 percent (rather than 21 percent), the foreign tax rate would generally need to be at least 23.4 percent (18.75 percent/80 percent) in order for the taxes deemed paid limitation in E.1 not to apply. Given that a limited number of foreign jurisdictions have a foreign tax rate that is at least 26.25 or 23.4 percent, the taxes deemed paid limit would in many situations apply. However, if a foreign tax rate is as high as 26.25 or 23.4 percent (as applicable), in applying GILTI on a country-by-country basis, taxpayers would be dismayed to find expense allocation and apportionment then kick in such that residual U.S. tax is owed.

    Conclusion
    As discussed above, some of the proposals will likely have considerable impacts on the effective tax rate on GILTI.

    Authors

    Caroline H. Ngo

    Partner

    Washington, DC

    More insights

  • NY HERO Act: Update to Model Plan

    NY HERO Act: Update to Model Plan

    ARTICLE / CLIENT ALERT

    NY HERO Act: Update to Model Plan

    September 28, 2021

    Read time: 4 min

    Key takeaways
    Overview

    Earlier this month, SRZ issued an Alert advising that, in light of the New York State Commissioner of Health’s Sept. 6, 2021 designation of COVID-19 as “a highly contagious communicable disease that presents a serious risk of harm to the public health” under the New York Health and Essential Rights Act of 2021 (“HERO Act”), employers were required to “promptly” implement and enforce their airborne infectious disease exposure prevention plans. Many employers adopted the New York State Department of Labor’s (“DOL”) Model Airborne Infectious Disease Exposure Prevention Plan (“Model Plan”), which, among other things, set forth requirements concerning face coverings and social distancing in the workplace regardless of vaccination-status. On Sept. 23, 2021, the DOL updated its Model Plan to amend these particular requirements.

    Amended Rules for Masks and Social Distancing in the Workplace

    The Model Plan was revised to permit voluntary mask-wearing in workplaces where all individuals are fully vaccinated. More specifically, the Model Plan now provides: “[APPLICABLE FOR WORKPLACES where all individuals on premises, including but not limited to employees, are fully vaccinated – defined as having completed a federally authorized or approved vaccination series for an airborne infectious disease designated as a highly contagious communicable disease that presents a serious risk of harm to the public health (as is currently the case for COVID-19, pursuant to the Commissioner of Health’s designation)]. Appropriate face coverings are recommended, but not required, consistent with State Department of Health and the Centers for Disease Control and Prevention applicable guidance, as of Sept. 16, 2021.” For all other workplaces, employees are required to wear appropriate face coverings in accordance with guidance from the New York State Department of Health or the Centers for Disease Control and Prevention, as applicable.

    The Model Plan’s requirements concerning social distancing were also amended. Whereas the previous iteration of the Model Plan advised that “unnecessary gatherings” should be avoided and that employees must “use a face covering when physical distance cannot be maintained,” the updated Model Plan now provides only that “physical distancing will be used, to the extent feasible, as advised by guidance from State Department of Health or the Centers for Disease Control and Prevention, as applicable.”

    What Employers Should Do Now

    Employers may, if they prefer the revised Model Plan over its predecessor, “update” their airborne infectious disease exposure prevention plans to reflect the updated Model Plan. While there currently is no specific guidance on updating prevention plans aside from the DOL’s FAQ Guidance that advises employers to regularly review and update their prevention plans, employers should, after updating their plans, promptly post the revised prevention plan in the workplace, update employee handbooks to include the revised plan, if applicable, and inform employees of the change to the prevention plan alongside a copy of the updated plan.

    Please be advised that if you adopted an “alternative” airborne infectious disease exposure prevention plan (i.e., any plan other than the Model Plan), these changes may not affect you because you must continue to adhere to the specific terms of your adopted plan, including with respect to wearing masks and social distancing in the workplace (provided the minimum standards set forth in the DOL’s Airborne Infectious Disease Exposure Prevention Standard are met).

    As always, if you have any specific questions about the HERO Act or how it impacts your organization, you should contact your SRZ attorney.

    Authored by Mark E. Brossman, Ronald E. Richman, Max Garfield, Scott A. Gold, Donna K. Lazarus and Abdulrahman Alwattar.


    This communication is issued by Schulte Roth & Zabel LLP for informational purposes only and does not constitute legal advice or establish an attorney-client relationship. In some jurisdictions, this publication may be considered attorney advertising. ©2021 Schulte Roth & Zabel LLP.

    All rights reserved. SCHULTE ROTH & ZABEL is the registered trademark of Schulte Roth & Zabel LLP.

    In depth
    Authors

    Mark E. Brossman

    Partner

    New York – 919 Third Avenue

    Ronald E. Richman

    Partner

    New York – 919 Third Avenue

    Max Garfield

    Partner

    New York – 919 Third Avenue

    Donna K. Lazarus

    Partner

    New York – 919 Third Avenue

    Abdulrahman Alwattar

    Associate

    New York – 919 Third Avenue

    More insights

  • Federal Contractor COVID-19 Vaccine Mandate Clock Is Ticking

    Federal Contractor COVID-19 Vaccine Mandate Clock Is Ticking

    ARTICLE / CLIENT ALERT

    Federal Contractor COVID-19 Vaccine Mandate Clock Is Ticking

    September 27, 2021

    Read time: 6 min

    Key takeaways
    Overview

    UPDATE (12/22/2021):

    As of December 15, 2021, the CMS IFR has been reinstated in 25 states. As of December 17, 2021, the OSHA “vax or test” ETS has been reinstated nationwide, with enforcement dates beginning in January 2022. The federal contractor mandate remains under a nationwide stay, with no enforcement currently permitted. Read more here.


    On September 24, 2021, the Safer Federal Workforce Task Force (the Task Force) issued its initial guidance (the Guidance) for federal contractor COVID-19 safety mandates. The Guidance was issued pursuant to US President Joe Biden’s “Path Out of the Pandemic” Action Plan announced on September 9, 2021.

    Most notably, all covered federal contractors, subcontractors and their employees who work on covered contracts (i.e., those awarded or renewed as of November 14, 2021) must be fully vaccinated by December 8, 2021, if their contract so requires. This includes businesses of all sizes and also covers remote workers.

    In depth

    The enforcement mechanism with regard to contractors is largely contractual. President Biden’s executive orders enforcing the “Path Out of the Pandemic” Action Plan require federal agencies to contractually require their contractors to follow all Task Force Guidance. Therefore, once a federal contractor’s contract has been updated to include a requirement for compliance with the Guidance, the Guidance should be viewed as enforceable rules that covered contractors are bound by.

    The Guidance issued on September 24, 2021, is comprised of three COVID-19 safety facets:

    1. COVID-19 vaccination of covered contractor employees, except in limited circumstances where an employee is legally entitled to an accommodation;
    2. Compliance by individuals, including covered contractor employees and visitors, with the Task Force’s Guidance related to masking and physical distancing while in covered contractor workplaces; and
    3. Designation by covered contractors of a person or persons to coordinate COVID-19 workplace safety efforts at covered contractor workplaces.

    WHICH CONTRACTS ARE COVERED

    President Biden’s Executive Order 14042 and the Guidance both require that certain federal contracts must include a clause requiring contractors and subcontractors to abide by the Guidance. While Executive Order 14042 dictates a lengthy explanation of which contracts are covered, the Guidance instructs agencies to construe the term “contracts” broadly. Only contracts that provide services to the federal government are covered; contracts only for the provision of products are not covered.

    With regard to timing of implementation:

    • For contracts awarded prior to October 15, 2021, where performance is ongoing, the clause requiring compliance with the Guidance must be incorporated when the contract is renewed or extended.
    • Between October 15, 2021, and November 14, 2021, agencies must include the required clause in the solicitation. For contracts awarded during this period, agencies are encouraged, but not required, to include the clause in contracts awarded during this period, unless the solicitation was issued on or after October 15, 2021.
    • For contracts awarded on or after November 14, 2021, the required clause must be incorporated into the contract’s terms.

    If the Guidance is then updated during the ongoing term of a contract, the terms will be deemed to apply to that covered contract for the remainder of its term.

    Prime contractors are responsible for ensuring that the required compliance clause is included in its first-tier subcontracts, and first-tier subcontractors are required to flow the clause down to their lower-tier subcontractors.

    VACCINE MANDATE

    The Guidance requires that covered contractors ensure that all employees who provide services in connection with a covered contract are fully vaccinated, unless entitled to an accommodation under applicable law, by December 8, 2021. Contractors must require proof of vaccination, such as a copy of the employee’s vaccination card; a self-attestation as to the employee’s vaccination status is not sufficient to meet the Task Force’s requirements.

    The Guidance does not contemplate any particular alternatives to the vaccine mandate for employees with exemptions, such as regular testing. As such, the Guidance is silent as to whether the employer would need to pay for tests if this is granted as an accommodation to the employee.

    The vaccine mandate applies to contractors’ in-person and remote workers, but only to those who work within the United States. It applies to all covered contractors, regardless of the size of their workforce.

    Covered contractors do not need to provide on-site vaccination to employees.

    MASKING AND PHYSICAL DISTANCING

    The Guidance requires that all covered contractor employees and visitors must comply with the Centers for Disease Control and Prevention’s (CDC) masking and physical distancing guidelines when in a covered contractor workplace.

    At the time of this article, the CDC’s guidance states that in areas with high or substantial community transmission, all individuals (including fully vaccinated people) must wear masks indoors, but fully vaccinated people do not need to physically distance. Individuals who are not fully vaccinated must wear a mask indoors and in certain outdoor settings, regardless of the level of community transmission, and they must remain a distance of at least six feet from others at all times (where feasible).

    DESIGNATING A PERSON TO COORDINATE COVID-19 WORKPLACE SAFETY EFFORTS

    Covered contractors must designate a person or persons to coordinate implementation of and compliance with the Guidance at covered contractor workplaces. The designated individual must ensure that information on masking and distancing is distributed to covered employees and all other individuals likely to be present at the workplace. The designated individual may also be responsible for ensuring that all employees provide proof of vaccination.


    UPDATE (12/07/2021):

    On December 7, 2021, the US District Court for the Southern District of Georgia issued a nationwide injunction that blocks the federal government from enforcing the federal contractor and subcontractor vaccine mandate. The preliminary injunction issued is for the pendency of the litigation challenging the enforceability of the mandate filed by the states of Georgia, Alabama, Idaho, Kansas, South Carolina, Utah and West Virginia. This injunction order may be challenged on appeal.


    UPDATE (11/11/2021):

    On November 10, 2021, the Safer Federal Workforce Task Force updated its guidance for federal contractors to move the December 8, 2021, deadline to January 18, 2022. This means that covered contractor employees must receive their final vaccination shot by January 4, 2022, in order to be fully vaccinated by the January 18 deadline.

    Authors

    Abigail M. Kagan

    Partner

    New York – One Vanderbilt Avenue

    More insights

  • President Biden’s COVID-19 Action Plan: Will Your Company Be Required to Mandate Vaccination?

    President Biden’s COVID-19 Action Plan: Will Your Company Be Required to Mandate Vaccination?

    ARTICLE / CLIENT ALERT

    President Biden’s COVID-19 Action Plan: Will Your Company Be Required to Mandate Vaccination?

    September 24, 2021

    Read time: 7 min

    Key takeaways
    Overview

    UPDATE (12/22/2021):

    As of December 15, 2021, the CMS IFR has been reinstated in 25 states. As of December 17, 2021, the OSHA “vax or test” ETS has been reinstated nationwide, with enforcement dates beginning in January 2022. The federal contractor mandate remains under a nationwide stay, with no enforcement currently permitted. Read more here.


    On September 9, 2021, US President Joe Biden announced a multipronged plan to increase the number of Americans who are vaccinated for COVID-19. In the plan, titled “Path Out of the Pandemic: President Biden’s COVID-19 Action Plan,” the Biden administration provides for multiple regulatory and executive order-based means to encourage or require vaccination in various workplace settings.

    Specifically, some form of vaccine mandate will apply for employers with 100 or more employees; for most Centers for Medicare & Medicaid Services (CMS) regulated workplace settings; and for some federal contractors, as well as all federal executive branch workers.

    The plan, and President Biden’s federal employee and contractor executive orders, provide highlights of what is to come, but they leave many questions unanswered. These questions will be addressed in forthcoming emergency rules and standards issued by the US Occupational Safety and Health Administration (OSHA), CMS and Safer Federal Workforce Task Force (the Task Force) guidance.

    Here is what we know so far, and what we are waiting to learn:

    In depth

    ALL EMPLOYERS WITH 100 OR MORE EMPLOYEES MUST ENSURE VACCINATION OR REGULAR TESTING OF THEIR WORKFORCE.

    OSHA will develop a rule (known as an emergency temporary standard, or ETS) that will require all employers with at least 100 employees to ensure that each member of the workforce is either fully vaccinated or, for those who are not fully vaccinated, require such workers to produce a negative COVID-19 test result on at least a weekly basis before coming to work. As announced, it appears that the impending OSHA ETS will permit employers of 100 or more employees to present an option to all workers to either vaccinate or test (workers would be able to select either option).

    In addition, the OSHA ETS will require employers with more than 100 employees to provide paid time off for the time it takes for workers to get vaccinated or to recover if they are unwell post-vaccination.

    President Biden’s announcement did not address several questions, including: how employers are to count their employees for the 100-employee threshold (e.g., should multiple subsidiaries be aggregated); who pays for the COVID-19 testing (both time spent testing and reimbursement for any expenses); whether there will be reimbursement for the paid time off (similar to the Families First Coronavirus Response Act) or if this will be the employer’s burden to fund; whether there will be any cap to the vaccination-related paid time off; the deadline for compliance with the vaccination or testing requirement; or the anticipated timing for OSHA to release its ETS. The plan does state that the administration will be expanding free COVID-19 testing sites and working to lower the cost of at-home testing kits.

    Interestingly, while the plan states that the OSHA ETS will apply to employers with 100 or more “employees,” it also states that such employers must ensure that their “workforce” be vaccinated or tests; it also states that “workers” receive paid time off to get vaccinated. It is not clear whether the OSHA ETS will require employers to implement such vaccination or testing mandates (and such paid time off schemes) for non-employee workers such as independent contractors and volunteers.

    Employers should note that in June 2021, OSHA issued a different ETS imposing various COVID-related requirements on solely healthcare industry employers. The anticipated ETS requiring vaccination or testing has not yet been released as of the time of this article. Employers should exercise caution when researching requirements under “the OSHA ETS” to avoid referencing inapplicable regulations.

    FOR HEALTHCARE EMPLOYERS, MOST CMS-REGULATED SETTINGS WILL BE REQUIRED TO MANDATE VACCINATION FOR ALL WORKERS.

    CMS will issue an Interim Final Rule with Comment Period, to be issued in October, which will require COVID-19 vaccinations for workers in most healthcare facility settings that receive Medicare or Medicaid reimbursement. The Rule will cover—without limitation—hospitals, dialysis facilities, ambulatory surgical settings and home health agencies, in addition to nursing facilities (as was already announced by CMS prior to the administration’s plan).

    The CMS vaccination mandate will include nursing home staff as well as staff in hospitals and other CMS-regulated facility settings, and the definition of “worker” covered by the CMS Rule will be broad. As with some other state and local healthcare vaccination mandates, CMS’s rule will cover workers that are employees as well as non-employee workers in CMS-regulated facilities; this will include clinical staff, individuals providing services under arrangements, volunteers, and staff who are not involved in direct patient, resident or client care.

    The plan states that it will cover “most” CMS-regulated settings. Other than those specific types of facilities listed above, it is not yet clear how expansive CMS’s Interim Final Rule or the Rule will be.

    Recently, several state and local vaccination mandates have been issued with short turnaround times for compliance. Given that many vaccination regimens require two doses spaced apart by several weeks, with “fully vaccinated” status achieved only after 14 days past the final dose, CMS-regulated healthcare employers may choose to implement vaccination mandates ahead and in anticipation of the CMS Rule to avoid gaps in staffing caused by delayed vaccination. Many such organizations have done so.

    FEDERAL CONTRACTORS MUST COMPLY WITH THE EVER-EVOLVING SAFER FEDERAL WORKFORCE TASK FORCE GUIDANCE.

    President Biden issued two executive orders on September 9, 2021, one which requires executive branch federal employees to be vaccinated for COVID-19, subject to exceptions as required by law; and one which requires federal contractors to comply with all guidance issued by the Safer Federal Workforce Task Force. The Task Force guidance applies to any workplace where an individual works on a federal contract.

    As of the publication of this article, the Task Force’s latest guidance—in the form of model safety principles for federal agencies—was published on September 13, 2021. The guidance requires federal employees to be fully vaccinated, except in limited circumstances where an employee is legally entitled to a reasonable accommodation. Additional guidance is expected to be issued in the coming weeks, which will extend this vaccination requirement to workers who work on federal contracts.

    Although the executive order for federal contractors was effective “immediately,” it applies to new, extended or renewed contracts entered into, extended or renewed as of October 15, 2021, with some limited exceptions. As of that date, federal contractors subject to the executive order will also be required to include similar requirements in their contracts with subcontractors, requiring those subcontractor workers to be vaccinated absent a legally protected exception.

    In sum, contractors (and subcontractors) who are in the middle of a contract term are not required to implement these changes into the applicable contract until the term is extended or renewed, or the parties enter into a new contract, at which time the contract will be amended to require the contractor (or subcontractor) to comply with the Task Force guidance and vaccine mandate.

    Notably, the executive order applies only to contracts that fall into certain categories. One exception from the definition of “federal contracts” are federal grants.

    Note: On September 24, 2021, the Safer Federal Workforce Task Force published additional guidance for federal contractors. A client alert regarding the guidance is forthcoming.

    Authors

    Abigail M. Kagan

    Partner

    New York – One Vanderbilt Avenue

    Sandra M. DiVarco

    Partner

    Chicago

    More insights

  • HHS Announces Provider Relief Fund Period 1 Reporting Grace Period and Phase 4 Distribution

    HHS Announces Provider Relief Fund Period 1 Reporting Grace Period and Phase 4 Distribution

    ARTICLE / CLIENT ALERT

    HHS Announces Provider Relief Fund Period 1 Reporting Grace Period and Phase 4 Distribution

    September 23, 2021

    Read time: 4 min

    Key takeaways
    Overview

    On September 10, 2021, the US Department of Health and Human Services (HHS) Health Resources and Services Administration (HRSA) made several important announcements regarding the Provider Relief Fund (PRF) and its approaching Period 1 reporting deadline, including:

    • The long-awaited announcement of the PRF Phase 4 and American Rescue Plan (ARP) rural provider fund distributions
    • A 60-day grace period for the September 30, 2021, Period 1 reporting deadline
    • Detailed information regarding PRF Phase 3 payment methodology
    In depth

    New Phase 4 and ARP Distributions

    Eligible providers may apply for the $17 billion Phase 4 distribution beginning on September 29, 2021. HRSA will provide the application and additional eligibility information before that date. In the meantime, HRSA has provided the following details regarding the Phase 4 payment methodology:

    • Payments will be based on providers’ lost revenues and expenses related to the pandemic between July 1, 2020, and March 31, 2021 (consistent with the Coronavirus Response and Relief Supplemental Appropriations Act).
    • 75% of the Phase 4 allocation will be calculated based on COVID-19-related expenses and lost revenue.
    • Lost revenues and expenses of “small” providers will be reimbursed at a higher rate compared to “medium” and “large” providers. HHS will determine the amount of the base payments and supplemental payments after analyzing applications received.
    • 25% of the Phase 4 allocation will be paid as a bonus payment based on the amount and type of services provided to Medicare, Medicaid and Children’s Health Insurance Program (CHIP) patients.
    • HRSA will price Medicaid and CHIP claims data at Medicare rates, with limited exceptions, and certain rural providers will automatically receive a minimum bonus payment.

    Providers will apply for the $8.5 billion ARP rural payments using the same application as Phase 4. HRSA will pay ARP rural distributions to qualified providers based on the amount of Medicaid, CHIP and/or Medicare services they provide to patients living in rural areas.

    PRF Period 1 Reporting Grace Period

    HRSA also announced a 60-day grace period for PRF recipients that are unable to meet the September 30, 2021, reporting deadline. Providers that do not submit required reports by the deadline will be allowed to “come into compliance” with their reporting requirements by reporting prior to November 30, 2021. According to HRSA, these providers will not face collection activities or similar enforcement actions during the grace period. The deadline to use Period 1 PRF funds remains June 30, 2021. HRSA also notes that providers must return unused funds as soon as possible after submitting their report, and no later than December 30, 2021.

    Phase 3 Payment Details and Forthcoming Appeals Process

    For providers still questioning Phase 3 distributions, HRSA released detailed information regarding its Phase 3 payment methodology. Consistent with prior messaging (see, e.g., the General Information FAQ on appeals posted on July 15, 2021), providers who believe HRSA’s Phase 3 payment decisions were inconsistent with the released methodology will have an opportunity to request a reconsideration. PRF applicants who would like to receive updates regarding the reconsideration process under development should contact PRFReconsiderations@hrsa.gov.

    Continued Attention on Acquisition Activity

    Many PRF recipients have reported certain acquisition activity in connection with general distribution applications and Period 1 reports. HRSA’s latest announcement suggests a continued interest in this data “[t]o help ensure these provider funds are used for patient care.” Specifically, in an apparent new condition on Phase 4 and ARP funding, recipients will be required to notify HHS of any merger with, or acquisition of, another healthcare provider during the period of availability. HRSA notes that acquisition activity may subject recipients to heightened audit risk to verify that funds were used for COVID-19-related costs.

    Next Steps

    In light of these announcements, as healthcare providers finalize Period 1 reports, they should:

    • Evaluate the utility of the grace period as part of their overall PRF reporting and compliance strategy
    • Review the Phase 4 and ARP rural distribution eligibility criteria and payment methodologies and assess whether these distributions impact contemplated PRF allocations and reporting.

    In addition, healthcare providers pursuing Phase 4 or ARP payments, or who are considering Phase 3 reconsideration, should continue to monitor HRSA guidance for process updates and work with their outside advisors to prepare corresponding submissions.

    For additional resources, access McDermott’s Provider Relief Fund Toolkit, updated September 2021. 

    Authors

    Charles R. Buck

    Partner

    Boston

    More insights

  • NIST Issues Cybersecurity Framework for Ransomware Risk Management

    NIST Issues Cybersecurity Framework for Ransomware Risk Management

    ARTICLE / CLIENT ALERT

    NIST Issues Cybersecurity Framework for Ransomware Risk Management

    September 23, 2021

    Read time: 6 min

    Key takeaways
    Overview

    The Information Technology Laboratory (ITL) at the National Institute of Standards and Technology (NIST) recently issued a Ransomware Profile* identifying steps organizations can take to prevent, respond to and recover from ransomware events**. According to the profile, its “purpose…is to help organizations identify and prioritize opportunities for improving their security and resilience against ransomware attacks.” NIST encourages organizations to use the document as a guide for profiling the state of their own readiness and to identify gaps to achieve their goal.

    In depth

    Modeled on NIST’s Cybersecurity Framework Version 1.1, the profile provides practical guidance to organizations to protect against the ransomware threat, including the following “basic preventative steps”:

    • Use antivirus software at all times;
    • Keep computers fully patched, including scheduled checks and installation of patches “as soon as feasible”;
    • Segment networks;
    • Continuously monitor directory services (and other primary user stores) for indicators of compromise or active attack;
    • Use products or services to block access to server names, IP addresses, or ports and protocols that are known to be malicious or suspected to be indicators of malicious system activity;
    • Allow only authorized applications—including establishing processes for reviewing, adding or removing authorized applications—on an allowlist;
    • Use standard user accounts versus accounts with administrative privileges whenever possible;
    • Restrict personally owned devices on work networks;
    • Avoid using personal apps—like email, chat and social media—from work computers;
    • Educate employees about social engineering; and
    • Assign and manage credential authorization for all enterprise assets and software, and periodically verify that each account has the appropriate access only.

    The profile outlines steps that organizations “can take now” to help recover from a future ransomware event, including:

    • Develop and implement an incident recovery plan that has defined roles and strategies for decision-making and identifies business-critical services to enable recovery prioritization;
    • Carefully plan, implement and test a data backup and restoration strategy, with secure and isolated backups of important data; and
    • Maintain an up-to-date list of internal and external contacts for ransomware attacks.

    The profile applies the five foundational pillars of cybersecurity (i.e., identify, protect, detect, respond and recover) to ransomware. Based on this framework, organizations should, among other things:

    • Inventory assets, systems and processes, including where controls may be shared with third parties;
    • Ensure everyone in the organization understands their roles and responsibilities for preventing and responding to ransomware events, with documentation memorializing the structure;
    • Establish and communicate policies needed to prevent or mitigate ransomware events, which are in line with legal and regulatory requirements;
    • Factor ransomware risks into organizational risk management governance;
    • Ensure the ability to receive cyber threat intelligence from information-sharing sources;
    • Understand the business impact and expenses of potential ransomware events;
    • Implement an incident response plan that appropriately prioritizes ransomware events, has defined roles, contains both technical and business responses and is regularly tested (to ensure the plan and processes match changing organizational needs and structures, as well as new ransomware types and tactics);
    • Coordinate ransomware contingency planning with suppliers and third-party providers;
    • Conduct ongoing training regarding ransomware threats; and
    • Monitor personnel activity to detect insider threats, insecure staff practices and compromised credentials.

    NIST’s guidance comes on the heels of a variety of measures from the Biden administration to combat ransomware, including:

    In addition, a bipartisan group of US Senators has introduced the Cyber Incident Notification Act, which, if enacted, would require federal agencies, government contractors and critical infrastructure owners and operators to report cyber intrusions to CISA within 24 hours of their discovery. A number of states—including New York, North Carolina, Pennsylvania and Texas—are considering legislation that would ban or restrict state and local government agencies from paying ransom in the event of a cyberattack.

    NIST’s recent guidance and the parallel executive and legislative branch action underscore that ransomware is both a top-of-mind concern across the government and that there may be heightened expectations for what constitutes reasonable cybersecurity measures.

    *Ransomware is a type of malware that encrypts an organization’s data, with cyber actors demanding payment as a condition of restoring access to that data. In some instances, the cyber actors also may steal an organization’s information and demand an additional payment in return for not disclosing the information to authorities, competitors or the public.

    **NIST’s National Cybersecurity Center of Excellence (NCCoE) has produced additional reference materials intended to support ransomware threat mitigation. These include: NIST Special Publication (SP) 1800-26, Data Integrity: Detecting and Responding to Ransomware and Other Destructive Events, which addresses how an organization can handle an attack when it occurs and what capabilities it needs to have in place to detect and respond to destructive events; NIST SP 1800-25, Data Integrity: Identifying and Protecting Assets Against Ransomware and Other Destructive Events, which addresses how an organization can work before an attack to identify its assets and potential vulnerabilities and remedy the discovered vulnerabilities to protect these assets; NIST SP 1800-11, Data Integrity: Recovering from Ransomware and Other Destructive Events, which addresses approaches for recovery should a data integrity attack be successful; and Protecting Data from Ransomware and Other Data Loss Events, which is a guide for managed service providers to conduct, maintain and test backup files that are critical to recovering from ransomware attacks.

    Authors

    Michael G. Morgan

    Partner

    Los Angeles, Silicon Valley

    David P. Saunders

    Partner

    Chicago

    More insights

  • Illinois Appellate Court Rules on BIPA Statute of Limitations

    Illinois Appellate Court Rules on BIPA Statute of Limitations

    ARTICLE / CLIENT ALERT

    Illinois Appellate Court Rules on BIPA Statute of Limitations

    September 21, 2021

    Read time: 5 min

    Key takeaways
    Overview

    On September 17, 2021, a panel of the Illinois Appellate Court for the First District issued a significant decision on the question of which statute of limitations apply to claims under the Illinois Biometric Information Privacy Act (BIPA), 740 ILCS 14/15.

    In depth

    In Tims v. Black Horse Carriers, Inc., No. 1-20-0563, 2021 IL. App. (1st) 200563 (Sept. 17, 2021), the three-judge panel ruled that BIPA claims brought under sections 15(a), (b), and (e) of the statute—which are claims requiring companies to have publicly available policy, obtain informed consent and safeguard data—are subject to a five-year limitations period. BIPA claims brought under sections 15(c) and (d) of the statute, which are claims that prohibit profiting from or disclosure of biometric data, are subject to a one-year limitations period.

    Under the Illinois Code of Civil Procedure, section 13-201 establishes a one-year statute of limitations for “[a]ctions for slander, libel or for publication of matter violating the right of privacy,” 735 ILCS 5/13-201. Section 13-205 establishes a five-year statute of limitations for “all civil actions not otherwise provided for,” 735 ILCS 5/13-205. Plaintiff Tims argued that the default limitation period of section 13-205 should apply, while Defendant Black Horse Carriers, Inc. argued that because BIPA concerns privacy, the shorter limitations period for privacy actions under 13-201 should apply.

    In reaching its decision that different limitations periods apply to different BIPA claims, the panel concluded “that section 13-201 does not encompass all privacy actions but only those where publication is an element or inherent part of the action.” An entity could violate BIPA section 15(a) by failing to develop a written policy establishing a retention schedule and destruction guidelines, section 15(b) by collecting biometric data without written notice and release or 15(e) by not taking reasonable care in protecting biometric data. Because the duties imposed under sections 15(a), (b) and (e) do not have an element of publication or dissemination, the five-year catchall limitations period under section 13-205 applies. This holding by the panel could also have ramifications beyond BIPA given that foreclosure of the notion that Section 13-201 is the default for all types of privacy claims.

    On the other hand, an entity could violate BIPA section either 15(c) by selling or trading biometric data or section 15(d) by disclosing or disseminating biometric data without consent. The panel reasoned that since “publication or disclosure of biometric data is clearly an element” under sections 15(c) and (d), the one-year limitations period for violating the right of privacy under 13-201 applies.

    The panel noted that applying different limitations periods for different BIPA violations is appropriate because each duty under BIPA is “separate and distinct.” The panel further reasoned that under BIPA section 20, “[a] private entity could violate one of the duties while adhering to the others,” and a plaintiff that “proves violation of multiple duties could collect multiple recoveries of liquidated damages.” See 740 ILCS 14/20.

    In practice, Tims could result in some more narrow class definitions and more subclasses being proposed. However, this opinion is unlikely to stem the tsunami of BIPA cases that have inundated the state and federal courts of Illinois.

    Although the Tims decision answers the statute of limitations question, several other issues relevant to BIPA litigation are currently pending in state and federal Illinois appellate courts. For example, the issue of when a claim accrues under the BIPA is currently before the US Court of Appeals for the 7th Circuit. And in McDonald v. Symphony Bronzeville, the Illinois Supreme Court will decide whether the Illinois Workers’ Compensation Act pre-empts BIPA claims arising in the employment context. Last, but not least, the Illinois Appellate Court for the Third District is also considering the question of whether a one-year, two-year or five-year statute of limitations applies to claims under the BIPA. The Marion appeal is stayed pending the Illinois Supreme Court’s decision in McDonald, and it quite likely will be influenced by the Tims decision. If the Third District were to reach a different conclusion on the question of the limitations period applicable to BIPA, that split would inevitably lead to the issue going before the Illinois Supreme Court.

    In short, while Tims may be a road marker in the statute of limitations battle over BIPA, it may not be the end of the road.

    Authors

    David P. Saunders

    Partner

    Chicago

    More insights

  • CMS Resumes Provider and Supplier Enrollment Activities Paused During Pandemic

    CMS Resumes Provider and Supplier Enrollment Activities Paused During Pandemic

    ARTICLE / CLIENT ALERT

    CMS Resumes Provider and Supplier Enrollment Activities Paused During Pandemic

    September 21, 2021

    Read time: 3 min

    Key takeaways
    Overview

    The Centers for Medicare and Medicaid Services (CMS) has started phasing out certain program flexibilities granted during the COVID-19 public health emergency. Beginning in October 2021, CMS will resume several provider and supplier enrollment activities that were paused during the pandemic.

    In depth

    The Centers for Medicare and Medicaid Services (CMS) indicated in FAQs issued in August 2021 that it will resume several Medicare enrollment activities that were paused during the public health emergency (PHE). The announcement continues the unwinding process for certain flexibilities that CMS afforded providers earlier in the pandemic. CMS will retain some flexibilities that have been established with explicit expiration dates by statute or regulation (typically some period of time after the end of the PHE), but has made clear that not all flexibilities are viewed as essential despite the ongoing pandemic.

    The Medicare enrollment activities that will recommence in October 2021 include:

    • Revalidation
    • Application Fees
    • Fingerprint-based criminal background checks.

    Revalidation notices under 42 CFR 424.515 will be issued in a phased approach with due dates starting in early 2022. Application fees under 42 CFR 424.514 will be required from institutional providers that are initially enrolling in Medicare, adding a practice or location, or revalidating their enrollment information. Fingerprint-based criminal background checks, in accordance with 42 CFR 424.518, will also resume for “high risk categories of providers and suppliers,” such as newly enrolling home health agencies; opioid treatment programs; and suppliers of durable medical equipment, prosthetics/orthotics and supplies.

    The reinstated revalidations, application fees and fingerprint-based criminal background checks will not apply to providers and suppliers that received temporary billing privileges through the Medicare enrollment hotlines during the PHE. After the PHE is lifted, those providers and suppliers will be required to submit a complete CMS-855 enrollment application in order to establish full Medicare billing privileges, at which time application fees and fingerprint-criminal background checks will be required, if applicable.

    CMS has indicated that it may resume additional provider enrollment enforcement activities in the coming months. These changes are part of a larger agency movement towards greater program integrity enforcement. In March 2021, CMS announced it would resume onsite visits and surveys of hospitals to verify conditions of participation. Providers should be vigilant to ensure they are not relying on flexibilities that have been discontinued.

    Authors

    Emily Jane Cook

    Partner

    Los Angeles, Washington, DC

    Monica Wallace

    Partner

    Chicago

    More insights